The global In-Vitro Diagnostics (IVD) market is transitioning from "instrument-centric" to "workflow-centric" models. Modern labs demand seamless integration between raw sample handling and final data reporting to reduce human error and turnaround time (TAT).
Leveraging Shenzhen's unique MedTech ecosystem, we provide a 30% faster R&D cycle than Western counterparts. Our "Speed-to-Market" advantage is backed by a complete local supply chain, from precision microfluidics to AI-driven software.
Decentralization of testing and "Lab-on-a-Chip" technologies are dominating. We are currently integrating Cloud-based data management and multi-plex PCR capabilities into our OEM/ODM frameworks for the next generation of precision medicine.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
We provide full-stack hardware development including high-precision thermal cycling modules, optical detection systems (FAM/HEX/ROX/CY5), and automated liquid handling robotics. Our systems are built to withstand rigorous clinical environments.
Our workflow solutions include LIS/HIS connectivity, automated result interpretation, and cloud-based monitoring. We enable our partners to offer "Smart Diagnostic" features with minimal development overhead.
Navigating CE-IVD, FDA, and local certifications is complex. BioX Medical provides full documentation support and quality management systems (ISO 13485) to ensure your customized product is market-ready.
By centralizing production in Shenzhen, we mitigate global logistics risks. We offer scalable production from small-batch prototyping to high-volume commercial manufacturing.
High-throughput automated systems for rapid respiratory, gastrointestinal, and STI panel testing, reducing laboratory workload by 40%.
Providing the foundational PCR or NGS prep hardware so innovators can focus on their proprietary chemistry and biomarker discovery.
Applying molecular diagnostic workflows to food safety, veterinary health, and environmental monitoring for pathogen detection.
For standard hardware modifications, the prototype lead time is 8-12 weeks. Fully customized "ground-up" developments typically take 6-9 months depending on regulatory requirements.
Yes, our diagnostic workflow solutions are designed with flexibility. We offer both closed systems (for reagent lock-in models) and open platforms for third-party kit compatibility.
We provide a 24-month warranty and technical training for your local engineers. We also offer cloud-based remote diagnostics to troubleshoot software issues in real-time.
Absolutely. We have a dedicated regulatory affairs team that prepares technical files for CE, FDA, and various national health authorities (e.g., NMPA, TGA).
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
BioX Medical
